Emerging Strategies and Advances in Treatment of Solid Tumors and Hematological Malignancies for Practicing Physicians and Healthcare Professionals 2012

Key Topics

• Optimal use of EGFR TKI’s, VEGF TKIs and EML4/ALK targeted agents based on biomarkers for lung cancer
• Histology in patient selection for integration of targeted therapy for lung cancer
• VEGF and EGFR based combination therapy for colorectal cancer
• Treating breast cancer patients with integration of novel cytotoxic agents including antibody-drug conjugates
• Novel treatment options for pancreatic neuroendocrine tumors and pancreatic cancer
• Multidisciplinary approaches in the management of rectal cancer
• Emerging treatment options for renal cell carcinoma
• New therapeutic options for prostate cancer
• Novel therapies for lymphomas
• New therapeutic options in the management of malignant melanoma
• Updates in the treatment of leukemia
• Novel approaches in the treatment of relapsed multiple myeloma
• Practice guidelines and their impact on reimbursement issues in cancer treatment
• Supportive cancer care in the era of targeted therapy

Who should Attend

Radiation oncologists, oncologists/hematologists, researchers, surgical oncologists, registered nurses, registered pharmacists, physician assistants, urologists and nurse practitioners.